Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)   JANUARY 2010 , Volume 4 , Number 1; Page(s) 74 To 77.
 
Paper: 

SURVIVAL AT 1, 3, AND 5 YEARS IN DIABETIC AND NONDIABETIC PATIENTS ON HEMODIALYSIS

 
 
Author(s):  BELADI MOUSAVI SEYED SEYF ELAH*, HAYATI F., ALEMZADEH ANSARI M.J., VALAVI E., CHERAGHIAN B., SHAHBAZIAN H.A., GOLZARI KH., GHORBANI ALI, RASHIDI H., PAYAMI SEYED PEYMAN, GHADERIAN B., EYDENI E.
 
* DEPARTMENT OF INTERNAL MEDICINE, FACULTY OF MEDICINE, JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES, AHVAZ, IRAN
 
Abstract: 

We analyzed survival of 185 adult patients on maintenance hemodialysis (9 h/wk to 12 h/wk) at Emam Khomini Hospital in Ahvaz, Iran. Patient survival at 1, 3, and 5 years was 89.2%, 69.2%, and 46.8%, respectively. There was no significant difference between diabetic and nondiabetic patients in 1-year survival (87.1% versus 89.7%, P = .66). But, 3- and 5-year survival rates of diabetic patients were significantly lower than those of nondiabetic patients (52.2% versus 73.8%, P = .04; zero versus 56.9%, P < .001; respectively). Based on our findings, the survival of diabetic patients undergoing hemodialysis was much worse than survival of nondiabetic patients. Thus, prevention of diabetic nephropathy should be more emphasized; and if end-stage renal disease is present, other renal replacement therapies such as kidney transplantation must be considered as soon as possible.

 
Keyword(s): DIABETIC NEPHROPATHY, END-STAGE RENAL DISEASE, HEMODIALYSIS, SURVIVAL
 
References: 
  • ندارد
 
  pdf-File tarjomyar Yearly Visit 113
 
Latest on Blog
Enter SID Blog